Prescribing information


This page/content is for Great Britain Healthcare professionals only. If you require information for Northern Ireland please refer to the Northern Ireland PI



Below are a selection of resources to help you and your patients stay on track with PIQRAY® + fulvestrant.


Piqray Resources for Healthcare Professionals


Thumbnail of PIQRAY Management Guide document


A brochure to provide guidance on the management of specific adverse events that your patients on PIQRAY® + fulvestrant may experience, and how to deliver the treatment with appropriate medical management.

Download a digital copy

Screenshot from the video: Dr Paul Nathan discusses the COMBI-AD trial


For relevant journal publications, including a SOLAR-1 study reprint, please contact Novartis.

Download a digital copy



A video depicting the mechanism of action for PIQRAY® against the PIK3CA mutation in HR+/HER2– advanced breast cancer.



Piqray Resources for Patients


Preview of 'Your guide to managing pyrexia'


A booklet for you to share with your patients, to help them understand more about the treatment they have been prescribed.

Download a digital copy  Request a hard copy  



A website for patients in Great Britain who have been prescribed this medicine, to allow them to find out more about their treatment with PIQRAY® plus fulvestrant, such as how it works and the side effects they might experience. Please visit and use the password: connect@illuminatingABC

Access the patient website (GB HCPs to share with GB patients only)


As the site grows, we will be adding lots of new content. SIGN UP to receive our email communications and make sure you don’t miss the latest updates.

Rate this content: 
Average: 4 (1 vote)
UK | October 2023 | 307248

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]